Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery

NCT00450879 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

19

Enrollment

NIH

Sponsor class

Conditions

Male Breast Carcinoma
Recurrent Breast Carcinoma
Stage IA Breast Cancer
Stage IB Breast Cancer
Stage IIA Breast Cancer
Stage IIB Breast Cancer
Stage IIIA Breast Cancer

Interventions

DRUG: Pazopanib Hydrochloride
PROCEDURE: Dynamic Contrast-Enhanced Magnetic Resonance Imaging
OTHER: Pharmacological Study
OTHER: Laboratory Biomarker Analysis

Sponsor

National Cancer Institute (NCI)